Scenario | Quadrivalent vs No vaccination | Bivalent vs No vaccination | Bivalent vs Quadrivalent | ||||||
---|---|---|---|---|---|---|---|---|---|
∆QALYs | ∆COSTS | ICER | ∆QALYs | ∆COSTS | ICER | ∆QALYs | ∆COSTS | ICER | |
Scenario | |||||||||
 2: Both vaccines = 8.5 US$;  2-dose scheme - FX 6.3 | 4,395 | −805.7 US$ | cost-saving | 4,486 | −735.9 VEF | cost- saving | 91 | 69.8 VEF | 0.77 |
 4: Both vaccines = 8.5 US$;  2-dose scheme - FX: 170 | −106.4 US$ | cost- saving | −36.6 VEF | cost- saving | 69.8 VEF | 0.77 | |||
 6: BV: 8.5 US$ QV: 13.79 US$;  2-dose scheme - FX 6.3 | −788.9 US$ | cost- saving | −735.9 VEF | cost- saving | 53.0 VEF | 0.58 | |||
 8: BV: 8.5 US$ QV: 13.79 US$;  2-dose scheme - FX: 170 | 345.5 US$ | 0.08 | −36.6 VEF | cost-saving | −382.1 VEF | cost-saving |